FasL expression was induced by tumor-derived VEGF-A, IL-10 and prostaglandin E2 and pharmacological inhibition of these factors resulted in lower FasL expression and consequently higher CD8+ T cell infiltration by preventing effector T cell apoptosis (Motz et al., 2014) (Figure 1C). Here, FASLG is linked to neoplasm.